Phase III data for fenfluramine oral solution in the treatment of seizures associated with Dravet syndrome

In Study 3 (n=143), the addition of fenfluramine (0.7mg/kg/day) to the existing antiepileptic medication regimen was associated with a 64.8% relative reduction in mean monthly convulsive seizures versus placebo (73.7% versus 7.6% mean reduction, respectively; p<0.0001).

Source:

Biospace Inc.